AAAAAA

   
Results: 1-11 |
Results: 11
Harnessing the clinical potential of antiepileptic drug therapy - Dosage optimisation
Authors: Perucca, E Dulac, O Shorvon, S Tomson, T
Citation: E. Perucca et al., Harnessing the clinical potential of antiepileptic drug therapy - Dosage optimisation, CNS DRUGS, 15(8), 2001, pp. 609-621
Pyrrolidone derivatives
Authors: Shorvon, S
Citation: S. Shorvon, Pyrrolidone derivatives, LANCET, 358(9296), 2001, pp. 1885-1892
The management of status epilepticus
Authors: Shorvon, S
Citation: S. Shorvon, The management of status epilepticus, J NE NE PSY, 70, 2001, pp. 22-27
Patients' perspectives on services for epilepsy: a survey of patient satisfaction, preferences and information provision in 2394 people with epilepsy
Authors: Poole, K Moran, N Bell, G Solomon, J Kendall, S McCarthy, M McCormick, D Nashef, L Johnson, A Sander, J Shorvon, S
Citation: K. Poole et al., Patients' perspectives on services for epilepsy: a survey of patient satisfaction, preferences and information provision in 2394 people with epilepsy, SEIZURE-E J, 9(8), 2000, pp. 551-558
NHS services for epilepsy from the patient's perspective: a survey of primary, secondary and tertiary care access throughout the UK
Authors: Moran, N Poole, K Bell, G Solomon, J Kendall, S McCarthy, M McCormick, D Nashef, L Johnson, A Sander, J Shorvon, S
Citation: N. Moran et al., NHS services for epilepsy from the patient's perspective: a survey of primary, secondary and tertiary care access throughout the UK, SEIZURE-E J, 9(8), 2000, pp. 559-565
Oxcarbazepine: a review
Authors: Shorvon, S
Citation: S. Shorvon, Oxcarbazepine: a review, SEIZURE-E J, 9(2), 2000, pp. 75-79
Assessing risk to benefit ratio in antiepileptic drug therapy
Authors: Perucca, E Beghi, E Dulac, O Shorvon, S Tomson, T
Citation: E. Perucca et al., Assessing risk to benefit ratio in antiepileptic drug therapy, EPILEPSY R, 41(2), 2000, pp. 107-139
Topiramate
Authors: Heaney, D Shorvon, S
Citation: D. Heaney et S. Shorvon, Topiramate, HANDB EXP P, 138, 1999, pp. 465-484
Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series
Authors: Moran, NF Fish, DR Kitchen, N Shorvon, S Kendall, BE Stevens, JM
Citation: Nf. Moran et al., Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series, J NE NE PSY, 66(5), 1999, pp. 561-568
Epilepsy needs revisited: a revised epilepsy needs document for the UK
Authors: Brown, S Betts, T Crawford, P Hall, B Shorvon, S Wallace, S
Citation: S. Brown et al., Epilepsy needs revisited: a revised epilepsy needs document for the UK, SEIZURE-E J, 7(6), 1998, pp. 435-446
Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2052922 and age-specific fertility rates of women withepilepsy
Authors: Wallace, H Shorvon, S Tallis, R
Citation: H. Wallace et al., Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2052922 and age-specific fertility rates of women withepilepsy, LANCET, 352(9145), 1998, pp. 1970-1973
Risultati: 1-11 |